The Food and Drug Administration (FDA) is forecasting a funding opportunity for the establishment of a Center for Research on Complex Generics through a cooperative agreement. This initiative aims to enhance collaboration with the generic drug industry by addressing scientific challenges in generic product development and assessment, while also facilitating research coordination among FDA, academia, and industry stakeholders. The Center will play a crucial role in advancing the FDA's mission to ensure patient access to high-quality, safe, and effective generic drugs, with a funding ceiling of $1.5 million for the fiscal year 2025. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610 for further details.